Literature DB >> 18793854

Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation.

Ji Hun Byun1, HyeYun Kim, YoungSoo Kim, Inhee Mook-Jung, Dong Jin Kim, Won Koo Lee, Kyung Ho Yoo.   

Abstract

The synthesis of a novel series of aminostyrylbenzofuran derivatives 1a-w and their inhibitory activities for Abeta fibril formation were described. All the synthesized compounds were evaluated by thioflavin T (ThT) assay and displayed potent inhibitory activities for Abeta fibril formation. Among them, compounds 1i and 1q exhibited excellent inhibitory activities (IC(50)=0.07 and 0.08 microM, respectively) than those of Curcumin (IC(50)=0.80 microM) and IMSB (IC(50)=8.00 microM) as reference compounds. Both compounds were selected as promising candidates for further biological evaluation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18793854     DOI: 10.1016/j.bmcl.2008.08.111

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ-Fibrinogen Interaction and Aβ-Induced Contact System Activation.

Authors:  Pradeep K Singh; Masanori Kawasaki; Hanna E Berk-Rauch; Goushi Nishida; Takeshi Yamasaki; Michael A Foley; Erin H Norris; Sidney Strickland; Kazuyoshi Aso; Hyung Jin Ahn
Journal:  Biochemistry       Date:  2018-02-09       Impact factor: 3.162

2.  Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albida.

Authors:  Qin-Hu Sun; Yu Zhang; Gui-Xin Chou
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

3.  Curcumin promotes A-beta fibrillation and reduces neurotoxicity in transgenic Drosophila.

Authors:  Ina Caesar; Maria Jonson; K Peter R Nilsson; Stefan Thor; Per Hammarström
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

4.  QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomers.

Authors:  Oleksandr Brener; Tina Dunkelmann; Lothar Gremer; Thomas van Groen; Ewa A Mirecka; Inga Kadish; Antje Willuweit; Janine Kutzsche; Dagmar Jürgens; Stephan Rudolph; Markus Tusche; Patrick Bongen; Jörg Pietruszka; Filipp Oesterhelt; Karl-Josef Langen; Hans-Ulrich Demuth; Arnold Janssen; Wolfgang Hoyer; Susanne A Funke; Luitgard Nagel-Steger; Dieter Willbold
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

5.  Aminostyrylbenzofuran directly reduces oligomeric amyloid-β and reverses cognitive deficits in Alzheimer transgenic mice.

Authors:  Sang-Hyun Lee; YoungSoo Kim; Hye Yun Kim; Young Hoon Kim; Maeng Sup Kim; Jae Yang Kong; Mun-Han Lee; Dong Jin Kim; Young Gil Ahn
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

Review 6.  Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.

Authors:  Wen-Yu Wu; Yu-Chen Dai; Nian-Guang Li; Ze-Xi Dong; Ting Gu; Zhi-Hao Shi; Xin Xue; Yu-Ping Tang; Jin-Ao Duan
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

7.  Insight into the PTP1B Inhibitory Activity of Arylbenzofurans: An In Vitro and In Silico Study.

Authors:  Srijan Shrestha; Su Hui Seong; Seul Gi Park; Byung Sun Min; Hyun Ah Jung; Jae Sue Choi
Journal:  Molecules       Date:  2019-08-09       Impact factor: 4.411

8.  Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer's disease.

Authors:  Zaman Hasanvand; Rasoul Motahari; Hamid Nadri; Setareh Moghimi; Roham Foroumadi; Adileh Ayati; Tahmineh Akbarzadeh; Syed Nasir Abbas Bukhari; Alireza Foroumadi
Journal:  Front Chem       Date:  2022-08-09       Impact factor: 5.545

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.